SCH 56592.
D000818:Animals; D000935:Antifungal Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy; D014355:Chagas Disease / Q000188:drug therapy; D015507:Drugs, Investigational / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D005658:Fungi / Q000187:drug effects; D006801:Humans; D051379:Mice; D009181:Mycoses / Q000188:drug therapy* / Q000382:microbiology; D010272:Parasitic Diseases / Q000188:drug therapy; D014230:Triazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*
D000935:Antifungal Agents; D015507:Drugs, Investigational; D014230:Triazoles; C101425:posaconazole